COMMUNIQUÉS West-GlobeNewswire

Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
19/02/2025
Media Release COPENHAGEN, Denmark; February 19, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano and C hief D evelopment O fficer Judith Klimovsky will participate in a [...]
Lifeward Announces CEO Transition
19/02/2025
CEO Larry Jasinski to Retire Company Begins Search for New Leader to Drive Next Phase of Growth Company Provides Preliminary Full-Year 2024 Revenue Reschedules Virtual Investor Event Until Later in 2025 After Hiring of [...]
SANUWAVE Health to Participate in 37th Annual Roth Conference
19/02/2025
EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive [...]
Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution
19/02/2025
Food Industry Leader Teams With Ever After Foods to Accelerate Cultivated Meat Market Development KEMPTTHAL, Switzerland and HAIFA, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Foodtech innovator Ever After Foods (EAF) and [...]
Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts
19/02/2025
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The Eye Health Summit , a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event. Hosted and produced by [...]
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025
On-demand video webcast now available here LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural [...]
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
19/02/2025
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders Patent expands the identification of potential treatment candidates for AD04 [...]
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
19/02/2025
The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the European Medicines Agency MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- C3i [...]
Le Centre C3i, une compagnie canadienne, reçoit l'approbation de l’EMA pour fabriquer des produits de thérapie cellulaire pour le marché européen
19/02/2025
La société a reçu une certification de conformité aux Bonnes pratiques de fabrications (BPF) à la suite d’une inspection de leur installation à Montréal par l'Agence européenne des médicaments MONTRÉAL, 19 févr. 2025 ( [...]
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025
On-demand video webcast now available here BOSTON and LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody [...]
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
18/02/2025
Industry veteran CFO Frank Karbe brings more than 25 years of leadership experience in the biopharma industry transitioning companies from R&D to commercialization SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cidara [...]
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
18/02/2025
REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will [...]
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
18/02/2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market [...]
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
18/02/2025
SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
18/02/2025
Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial collaboration and [...]
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
18/02/2025
PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results [...]
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
18/02/2025
CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
18/02/2025
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of its common stock at [...]
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
18/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]

Pages